跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe
Approved
STANDARD
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
42f4ba7929d7c3a1
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
42f4ba7929d7c3a1
Product Name
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe
Artg Id
281470
Artg Name
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2017-11-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/96c9e7fb0cab00b75b52c5656dd7e3ec.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d99697291a8f3626839f543c084b2098.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
42f4ba7929d7c3a1
Type
Standard
Back to TGA Approvals